BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35248826)

  • 1. Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis.
    Xiao F; Xu F; Zhang H; Shuai X
    Biochem Biophys Res Commun; 2022 Apr; 600():101-108. PubMed ID: 35248826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma.
    Xu Y; Yao Y; Liu Y; Wang Z; Hu Z; Su Z; Li C; Wang H; Jiang X; Kang P; Sun D; Zhong X; Cui Y
    Aging (Albany NY); 2019 Apr; 11(7):1907-1917. PubMed ID: 30946694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
    Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
    J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1.
    Yuan Z; Xiong B; Liu L; Lu Y; Liu Y; Wang G; Qian Y; Diao B; Tu M
    J Biochem Mol Toxicol; 2024 Feb; 38(2):e23656. PubMed ID: 38348717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
    Xu Y; Leng K; Yao Y; Kang P; Liao G; Han Y; Shi G; Ji D; Huang P; Zheng W; Li Z; Li J; Huang L; Yu L; Zhou Y; Jiang X; Wang H; Li C; Su Z; Tai S; Zhong X; Wang Z; Cui Y
    Hepatology; 2021 Apr; 73(4):1419-1435. PubMed ID: 32750152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256.
    Chen S; Chen Z; Li Z; Li S; Wen Z; Cao L; Chen Y; Xue P; Li H; Zhang D
    Cell Death Dis; 2022 Jan; 13(1):94. PubMed ID: 35091535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
    Liu W; Yin C; Liu Y
    Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
    [No Abstract]   [Full Text] [Related]  

  • 10. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0008305-mediated miR-660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis.
    Yan F; Fan B; Wang J; Wei W; Tang Q; Lu L; Luo Z; Pu J; Yang SS
    Cancer Med; 2021 Feb; 10(3):833-842. PubMed ID: 33481351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.
    Gao S; Hu W; Huang X; Huang X; Chen W; Hao L; Chen Z; Wang J; Wei H
    Cell Signal; 2020 Aug; 72():109621. PubMed ID: 32240747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42.
    Liu S; Guan C; Sha X; Gao X; Zou X; Yang C; Zhang X; Zhong X; Jiang X
    Cell Signal; 2024 Jun; 118():111141. PubMed ID: 38492624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression.
    Xiong W; Zhang A; Xiao X; Liu W
    Bioengineered; 2022 Apr; 13(4):10191-10201. PubMed ID: 35435120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an
    Zailaie SA; Sergi CM
    Ann Clin Lab Sci; 2022 Jan; 52(1):73-85. PubMed ID: 35181620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.